A B-cell antigen is a substance or molecule specifically interacting with an antibody, and which may lead to the further production of antibody and an immunological response.
B-LYMPHOCYTE ANTIGENS
A B-cell antigen is a substance or molecule specifically interacting with
an antibody, and which may lead to the further production of antibody and an
immunological response. Typically B-lymphocyte antigens are proteins within
which the epitopes each consist of clusters of 5–20 amino acid residues.
B-lymphocyte epitopes arise most commonly from the three-dimensional folding of
proteins (i.e. conformational epitopes), although they may also consist of a
sequential linear sequence of amino acids within the polypeptide chain (linear
epitopes). As a general rule, there is a gradient of increasing immunogenicity
with increasing molecular weight of protein. Further, the higher the structural
complexity of the protein or polypeptide antigen, the higher the level of
immunogenicity it is likely to exhibit. Thus, a polypeptide comprising a single
amino acid such as polylysine will be expected to be a weaker immunogen than a
protein of equivalent molecular weight made up of a diverse range of amino
acids.
Polysaccharides tend not to be good
immunogens for B-lymphocytes. When a polysaccharide serves as the sole
immunogen, the humoral response obtained is termed ‘T-cell-independent’ because
the polysaccharide does not elicit helper T-lymphocyte cooperation. The consequences of a T-cell-independent humoral response include the lack
of production of memory B-cell populations and the lack of synthesis by the
plasma cell of the full range of antibody subclasses, i.e. T-cell-independent
humoral responses mainly involve the production of IgM antibody. For improved
immunogenicity carbohydrate antigens are conjugated to proteins which allow a
more effective ‘T-cell dependent’ humoral response, i.e. one that affords the
generation of memory B-cell populations and of the synthesis of the full range
of antibody subclasses. This strategy is used in a number of current vaccine
products, e.g. meningococcal group C conjugate vaccine contains the capsular
polysaccharide antigen of Neisseria meningitidis group
C conjugated to Corynebacterium diphtheriae protein.
Pure nucleic acid and lipid serve as very poor antigens.
Related Topics
TH 2019 - 2024 pharmacy180.com; Developed by Therithal info.